Michael Obadia is an expert in Neurology at Hôpital Fondation Adolphe de Rothschild (France). As of September 2026, ScienceLeadR ranks Michael Obadia in the top 1% of experts worldwide for Brain Ischemia and Cerebrovascular Disorders. Michael Obadia has authored 243 publications, the most recent in 2026, and is an investigator in 34 clinical trials, 5 of them ongoing. SLR score: 776 (community average: 125). How the SLR is computed.

LeadR Profile

776 ScienceLeadR Reputation 776
Network Map

Neurology

Subspecialties: Cardiology - Surgery - Public Health

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 1999 - 2026

Source: PubMed

Hôpital Fondation Adolphe de Rothschild

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 243

Citations

Citations: 12 845 1st author: 4 Last author: 13 Unique author: 0


Breakdown by type

Click a legend label to hide or show it in the chart.

Clinical Studies 34

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 2

By phase:

N/A 18
Phase 3 12
Phase 2 3
Phase 1/Phase 2 1

By status:

Completed 16
Recruiting 6
Terminated 6
Active not recruiting 2
Not yet recruiting 2
Unknown 2

By type:

Interventional 25
Observational 9

By Monocentric/Multicentric:

monocentric 13
multicentric2to4 3
multicentric5to9 3
multicentricup10 15

Main Topics

Cohort/Consortium Investigators 21

Ongoing Clinical Trials

5 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
A Phase 3 Placebo controlled Study of Milvexian after an Acute Ischemic Stroke or High Risk Transient Ischemic Attack
2022-501176-26-00 — safety, ischemic stroke, stroke, ischemic attack, transient, factor xia, factor xia inhibitor
Phase 3Active not recruiting2023
Intravenous Thrombolysis With Tenecteplase Plus Thrombectomy Versus Thrombectomy Alone In Patients With A Large Ischemic Stroke A Multicenter Randomized Controlled Trial (IVT ALL IN)
NCT07603440 — brain infarction, ischemic stroke, stroke, plasminogen, plasminogen activators, tissue plasminogen activator, administration, intravenous, brain, vascular diseases, reperfusion, cerebrovascular disorders, brain ischemia, tenecteplase, therapeutics, cerebral infarction, thrombectomy, ischemia
Phase 3Not yet recruiting2026
Acute Stroke Prehospital Versus In HospitAL Initiation of Recanalization Therapy ASPHALT
NCT05649670 — ischemic stroke, stroke, emergencies, triage, ambulances, angiography, reperfusion, therapeutics, thrombectomy, emergency medical services, computed tomography angiography
N/ARecruiting2023
Tenecteplase Treatment in Ischemic Stroke Registry
NCT05534360 — registries, ischemic stroke, stroke, brain, cardiovascular diseases, thrombolytic therapy, vascular diseases, brain diseases, cerebrovascular disorders, tenecteplase, therapeutics, nervous system, nervous system diseases, thrombectomy
N/ANot yet recruiting2022
PFO Closure Oral Anticoagulants or Antiplatelet Therapy After PFO associated Stroke in Patients Aged 60 to 80 Years
NCT05387954 — anticoagulants, foramen ovale, patent, ischemic stroke, stroke, rivaroxaban, clopidogrel, aneurysm, aspirin, cardiology, aged, factor xa inhibitors, therapeutics, factor xa, dabigatran, foramen ovale, apixaban
Phase 3Recruiting2023

LeadR Networks

Main global connection map